Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • SOP – Blog Post
  • Toggle search form

SOP for Archiving Study Documents

Posted on By

Protocol for Document Archiving in BA/BE Studies

Purpose

The purpose of this Standard Operating Procedure (SOP) is to establish guidelines for the systematic archiving and retention of study documents generated during Bioavailability (BA) and Bioequivalence (BE) studies in the pharmaceutical industry.

Scope

This SOP applies to all personnel involved in the conduct and oversight of BA/BE studies, including Study Coordinators, Data Managers, Clinical Research Associates (CRAs), and Quality Assurance personnel.

Responsibilities

  • The Study Coordinator is responsible for identifying study documents requiring archiving, organizing documents for archiving, and maintaining the archive inventory.
  • The Data Manager is responsible for managing electronic study documents, ensuring proper storage and backup procedures, and facilitating access to archived data.
  • The Clinical Research Associate (CRA) is responsible for verifying the completeness and accuracy of study documents before archiving and ensuring compliance with archiving procedures.
  • The Quality Assurance (QA) personnel are responsible for conducting periodic audits of the study archive, ensuring compliance with archiving procedures and regulatory requirements.
See also  SOP for Randomization and Blinding

Procedure

  1. Identify study documents requiring archiving based on regulatory requirements, study protocols, and sponsor guidelines.
  2. Organize study documents for archiving in a systematic manner, including paper documents, electronic files, and laboratory records.
  3. Label and index archived documents clearly, including study name, date, document type, and retention period, to facilitate retrieval and tracking.
  4. Store archived
documents in a secure and controlled environment, protected from environmental hazards such as fire, water damage, and unauthorized access.
  • Implement electronic archiving systems for managing electronic study documents, including version control, access restrictions, and audit trails.
  • Establish retention periods for study documents based on regulatory requirements and study protocols, and ensure that documents are retained for the required duration.
  • Regularly review archived documents to identify documents eligible for destruction or transfer to long-term storage, according to established retention schedules.
  • Document all archiving activities, including document inventory, storage locations, access logs, and disposal records, in accordance with regulatory requirements.
  • Abbreviations

    • SOP – Standard Operating Procedure
    • BA – Bioavailability
    • BE – Bioequivalence
    • CRA – Clinical Research Associate
    • QA – Quality Assurance

    Documents

    • Archive Inventory
    • Archiving Log
    • Document Retention Schedule
    • Access Control Policy

    Reference

    International Council for Harmonisation (ICH) E6 Good Clinical Practice guidelines and relevant regulatory requirements for document archiving and retention in clinical research.

    SOP Version

    Version 1.0

    See also  SOP for Sample Re-analysis Procedures
    Bioequivalence Bioavailability Study Tags:AUC (area under the curve), BE assessment, Bioavailability study, Bioequivalence study, clinical trials, Cmax (maximum concentration), Comparative pharmacokinetics, Drug absorption, Drug absorption rate, Drug bioanalysis, Drug development, Drug dissolution, Drug formulation, Drug metabolism, In vitro bioequivalence, In vivo bioavailability, Pharmacokinetic parameters, Pharmacokinetics, SOP for Bioavailability study, SOP for Bioequivalence study, Therapeutic equivalence, Tmax (time to maximum concentration)

    Post navigation

    Previous Post: SOP for Quality Control in Bioanalytical Labs
    Next Post: SOP for Final Report Preparation

    Standard Operating Procedures V 1.0

    • Aerosols
    • Analytical Method Development
    • Bioequivalence Bioavailability Study
    • Capsule Formulation
    • Clinical Studies
    • Creams
    • Data Integrity
    • Dental Dosage Forms
    • Drug Discovery
    • Environment, Health and Safety
    • Formulation Development
    • Gels
    • Good Distribution Practice
    • Good Warehousing Practices
    • In-Process Control
    • Injectables
    • Liquid Orals
    • Liposome and Emulsion Formulations
    • Lotions
    • Lyophilized Products
    • Maintenance Dept.
    • Medical Devices
    • Metered-Dose Inhaler
    • Microbiology Testing
    • Nanoparticle Formulation
    • Nasal Spray Formulations
    • Nebulizers
    • Ocular (Eye) Dosage Forms
    • Ointments
    • Otic (Ear) Dosage Forms
    • Pharmacovigilance
    • Powder & Granules
    • Purchase Departments
    • Quality Assurance
    • Quality Control
    • Raw Material Stores
    • Regulatory Affairs
    • Tablet Manufacturing
    • Rectal Dosage Forms
    • Transdermal Patches
    • Vaginal Dosage Forms
    • Validations and Qualifications

    Read SOPs in your Language:

     - 
    Bengali
     - 
    bn
    English
     - 
    en
    Gujarati
     - 
    gu
    Hindi
     - 
    hi
    Malayalam
     - 
    ml
    Marathi
     - 
    mr
    Punjabi
     - 
    pa
    Tamil
     - 
    ta
    Telugu
     - 
    te

    NEW! Revised SOPs – V 2.0

    • Aerosols V 2.0
    • Analytical Method Development V 2.0
    • API Manufacturing V 2.0
    • BA-BE Studies V 2.0
    • Biosimilars V 2.0
    • Capsules V 2.0
    • Creams V 2.0
    • Elixers V 2.0
    • Ointments V 2.0
    • Raw Material Warehouse V 2.0
    • Tablet Manufacturing V2.0

    New Publication: A must for All.

    Copyright © 2025 SOP Guide for Pharma.

    Powered by PressBook WordPress theme

    Go to mobile version